CBD for PCOS: New study shows potential against fatty liver, inflammation, and metabolic disorders

This combination of hormonal and metabolic problems significantly increases the long-term risk of type 2 diabetes, cardiovascular diseases, and chronic liver diseases. At the same time, classical therapeutic approaches such as dietary changes, metformin, or GLP-1 medications often reach their limits. Therefore, a new scientific study from 2025 focuses on another active ingredient: cannabidiol (CBD).

New Study 2025: CBD Improves Metabolism and Liver Health in PCOS

The study published in the journal Diabetes, Obesity and Metabolism titled “Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome” examined the effects of CBD in a preclinical mouse model with PCOS and androgenic obesity.

The researchers analyzed, among other things:

• Weight development
• Body fat percentage
• Insulin resistance
• Inflammatory markers
• Liver fibrosis
• Proteomic changes in the liver

The results were remarkable.

CBD Reduced Weight Gain and Fat Tissue

The treated animals showed significantly less weight gain as well as reduced fat deposits. Visceral fat plays a central role in PCOS, as it can amplify inflammatory processes and hormonal imbalances. The study suggests that CBD could positively influence energy metabolism.

Improvement of Insulin Resistance

A particularly important finding was the improvement of insulin sensitivity. Many women with PCOS suffer from pronounced insulin resistance, which in turn can exacerbate cravings, weight gain, and hormonal disorders. The researchers observed a significant improvement in metabolic markers under CBD, indicating a possible regulation of glucose metabolism.

CBD Showed Positive Effects on Fatty Liver (MASLD)

The results related to metabolic-associated fatty liver disease (MASLD) are especially exciting. Women with PCOS have a significantly increased risk of liver inflammation and fibrosis. In the study, CBD led to:

• lower inflammation levels
• reduced liver fibrosis
• improved liver markers
• changes in disease-relevant signaling pathways

Thus, CBD could play an interesting role in the future treatment of metabolic liver problems.

How Does CBD Work in PCOS and Metabolic Diseases?

The scientists explain the effects of cannabidiol through several biological mechanisms.

Anti-Inflammatory Properties

Chronic low-grade inflammation is now considered a central driver of many PCOS symptoms. CBD possesses strong anti-inflammatory properties that may regulate inflammatory signaling pathways. This could stabilize metabolic processes in the long term.

Influence on the Endocannabinoid System

CBD acts as a negative allosteric modulator of the CB1 receptor. This receptor plays an important role in:

• Appetite regulation
• Fat metabolism
• Energy balance
• Inflammatory responses

Overactivity of the CB1 system is often associated with obesity and metabolic diseases.

Activation of PPARγ and Nrf2

Additionally, CBD interacts with signaling pathways such as:

1. PPARγ → important for fat metabolism and insulin sensitivity
2. Nrf2 → central for antioxidant cellular protection

This combination makes CBD scientifically particularly interesting for complex metabolic diseases like PCOS.

Why Existing PCOS Therapies Often Are Not Enough

Currently, lifestyle changes are considered the most important first-line therapy for PCOS. However, many patients continue to struggle despite diet and exercise with:

• Weight gain
• Insulin resistance
• Hormonal imbalances
• Chronic inflammation

Medications such as metformin or GLP-1 receptor agonists also have limitations regarding:

1. Tolerability
2. Effectiveness
3. Availability
4. Individual response

Especially the inflammatory and fibrotic components of PCOS are often underestimated so far. This is exactly where CBD could become an interesting complementary therapy option in the future.

What Is the Significance of the Study for Women with PCOS?

The current investigation does not yet provide definitive clinical evidence in humans but is considered an important scientific milestone. The results show very clearly for the first time that CBD could simultaneously influence several central PCOS mechanisms:

• Metabolism
• Fat accumulation
• Inflammation
• Liver health
• Insulin resistance

Particularly relevant is the holistic approach. Instead of treating only individual symptoms, CBD could regulate various metabolic processes in parallel.

Limitations of the Study: What Is Still Missing

Despite the promising results, the authors emphasize several limitations.

No Direct Comparison Group with Metformin or GLP-1

The study did not directly compare CBD with established medications. Therefore, it is currently not possible to say whether CBD is stronger or weaker than existing therapies.

No Large-Scale Human Studies Yet

The results are based on a preclinical animal model. Clinical studies in women with PCOS are now necessary to:

• determine optimal dosages
• assess long-term safety
• investigate interactions
• examine therapeutic effects

in more detail.

Conclusion: CBD Could Open New Possibilities for PCOS

The new study from 2025 provides strong preclinical evidence that CBD could have therapeutic potential in PCOS, insulin resistance, fatty liver, and chronic inflammation. Particularly interesting is cannabidiol's ability to simultaneously influence several disease-relevant mechanisms. Thus, CBD could be used in the future as a complementary treatment for metabolic complications of PCOS. However, further clinical studies are required before an official medical recommendation can be made. Nevertheless, the research clearly shows: CBD is increasingly developing into an exciting candidate in modern metabolic medicine. Therefore, high-quality CBD oil could also establish itself as an interesting complementary support for women with PCOS, insulin resistance, and metabolic complaints in the future.

References:

Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome. Diabetes Obes Metab. 2025 Oct;27(10):6027-6031. doi: 10.1111/dom.16602. Epub 2025 Jul 9.

Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. Int J Mol Sci. 2025 Oct 2;26(19):9625. doi: 10.3390/ijms26199625.

HANAFSAN Blog: New Study Shows: CBD and CBG Could Influence Fatty Liver.

Images: HANAFSAN & ChatGPT